A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects with Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists

Trial Identifier: D6830C00001
Sponsor: AstraZeneca
NCTID:: NCT05110976
Start Date: December 2021
Primary Completion Date: July 2023
Study Completion Date: July 2023
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
DE Frankfurt, DE, 60596
DE Großhansdorf, DE, 22927
DE Magdeburg, DE, 39120
DE Wiesbaden, DE, 65187
GB London, GB, HA1 3UJ
GB NOTTINGHAM, GB, NG5 1PB
US, AZ Tempe, AZ, US, 85283
US, CA Glendale, CA, US, 91206
US, CA San Jose, CA, US, 95117
US, MA North Dartmouth, MA, US, 02747
US, MD White Marsh, MD, US, 21162
US, MO Kansas City, MO, US, 64114
US, NC Raleigh, NC, US, 27607
US, OR Portland, OR, US, 97202
US, TX El Paso, TX, US, 79903